The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Epigenetics Instrument-Global Market Insights and Sales Trends 2025
Synopsis
The global Epigenetics Instrument market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Epigenetics Instrument in various end use industries. The expanding demands from the Oncology, Metabolic Diseases, Developmental Biology and Immunology, are propelling Epigenetics Instrument market. Next-generation Sequencers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the qPCR Instruments segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Epigenetics Instrument market, driven by demand from China, the second largest economy with some signs of stabilising, the Epigenetics Instrument market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epigenetics Instrument, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epigenetics Instrument market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epigenetics Instrument market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epigenetics Instrument sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epigenetics Instrument covered in this report include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US) and Agilent (US), etc.
The global Epigenetics Instrument market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina (US)
Thermo Fisher (US)
Diagenode (Belgium)
QIAGEN (Netherlands)
Merck Millipore (US)
Abcam (UK)
Active Motif (US)
New England Biolabs (US)
Agilent (US)
Zymo Research (US)
PerkinElmer (US)
Bio-Rad (US)
Global Epigenetics Instrument market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epigenetics Instrument market, Segment by Type:
Next-generation Sequencers
qPCR Instruments
Mass Spectrometers
Sonicators
Other
Global Epigenetics Instrument market, by Application
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Epigenetics Instrument manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Epigenetics Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Epigenetics Instrument market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Epigenetics Instrument in various end use industries. The expanding demands from the Oncology, Metabolic Diseases, Developmental Biology and Immunology, are propelling Epigenetics Instrument market. Next-generation Sequencers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the qPCR Instruments segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Epigenetics Instrument market, driven by demand from China, the second largest economy with some signs of stabilising, the Epigenetics Instrument market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epigenetics Instrument, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epigenetics Instrument market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epigenetics Instrument market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epigenetics Instrument sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epigenetics Instrument covered in this report include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US) and Agilent (US), etc.
The global Epigenetics Instrument market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina (US)
Thermo Fisher (US)
Diagenode (Belgium)
QIAGEN (Netherlands)
Merck Millipore (US)
Abcam (UK)
Active Motif (US)
New England Biolabs (US)
Agilent (US)
Zymo Research (US)
PerkinElmer (US)
Bio-Rad (US)
Global Epigenetics Instrument market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epigenetics Instrument market, Segment by Type:
Next-generation Sequencers
qPCR Instruments
Mass Spectrometers
Sonicators
Other
Global Epigenetics Instrument market, by Application
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Epigenetics Instrument manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Epigenetics Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Epigenetics Instrument Market Overview
1.1 Epigenetics Instrument Product Overview
1.2 Epigenetics Instrument Market Segment by Type
1.2.1 Next-generation Sequencers
1.2.2 qPCR Instruments
1.2.3 Mass Spectrometers
1.2.4 Sonicators
1.2.5 Other
1.3 Global Epigenetics Instrument Market Size by Type
1.3.1 Global Epigenetics Instrument Market Size Overview by Type (2018-2029)
1.3.2 Global Epigenetics Instrument Historic Market Size Review by Type (2018-2023)
1.3.3 Global Epigenetics Instrument Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Epigenetics Instrument Sales Breakdown by Type (2018-2023)
1.4.2 Europe Epigenetics Instrument Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Epigenetics Instrument Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Epigenetics Instrument Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Epigenetics Instrument Sales Breakdown by Type (2018-2023)
2 Global Epigenetics Instrument Market Competition by Company
2.1 Global Top Players by Epigenetics Instrument Sales (2018-2023)
2.2 Global Top Players by Epigenetics Instrument Revenue (2018-2023)
2.3 Global Top Players by Epigenetics Instrument Price (2018-2023)
2.4 Global Top Manufacturers Epigenetics Instrument Manufacturing Base Distribution, Sales Area, Product Type
2.5 Epigenetics Instrument Market Competitive Situation and Trends
2.5.1 Epigenetics Instrument Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Epigenetics Instrument Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epigenetics Instrument as of 2022)
2.7 Date of Key Manufacturers Enter into Epigenetics Instrument Market
2.8 Key Manufacturers Epigenetics Instrument Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Epigenetics Instrument Status and Outlook by Region
3.1 Global Epigenetics Instrument Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Epigenetics Instrument Historic Market Size by Region
3.2.1 Global Epigenetics Instrument Sales in Volume by Region (2018-2023)
3.2.2 Global Epigenetics Instrument Sales in Value by Region (2018-2023)
3.2.3 Global Epigenetics Instrument Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Epigenetics Instrument Forecasted Market Size by Region
3.3.1 Global Epigenetics Instrument Sales in Volume by Region (2024-2029)
3.3.2 Global Epigenetics Instrument Sales in Value by Region (2024-2029)
3.3.3 Global Epigenetics Instrument Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Epigenetics Instrument by Application
4.1 Epigenetics Instrument Market Segment by Application
4.1.1 Oncology
4.1.2 Metabolic Diseases
4.1.3 Developmental Biology
4.1.4 Immunology
4.1.5 Cardiovascular Diseases
4.1.6 Other
4.2 Global Epigenetics Instrument Market Size by Application
4.2.1 Global Epigenetics Instrument Market Size Overview by Application (2018-2029)
4.2.2 Global Epigenetics Instrument Historic Market Size Review by Application (2018-2023)
4.2.3 Global Epigenetics Instrument Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Epigenetics Instrument Sales Breakdown by Application (2018-2023)
4.3.2 Europe Epigenetics Instrument Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Epigenetics Instrument Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Epigenetics Instrument Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Epigenetics Instrument Sales Breakdown by Application (2018-2023)
5 North America Epigenetics Instrument by Country
5.1 North America Epigenetics Instrument Historic Market Size by Country
5.1.1 North America Epigenetics Instrument Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Epigenetics Instrument Sales in Volume by Country (2018-2023)
5.1.3 North America Epigenetics Instrument Sales in Value by Country (2018-2023)
5.2 North America Epigenetics Instrument Forecasted Market Size by Country
5.2.1 North America Epigenetics Instrument Sales in Volume by Country (2024-2029)
5.2.2 North America Epigenetics Instrument Sales in Value by Country (2024-2029)
6 Europe Epigenetics Instrument by Country
6.1 Europe Epigenetics Instrument Historic Market Size by Country
6.1.1 Europe Epigenetics Instrument Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Epigenetics Instrument Sales in Volume by Country (2018-2023)
6.1.3 Europe Epigenetics Instrument Sales in Value by Country (2018-2023)
6.2 Europe Epigenetics Instrument Forecasted Market Size by Country
6.2.1 Europe Epigenetics Instrument Sales in Volume by Country (2024-2029)
6.2.2 Europe Epigenetics Instrument Sales in Value by Country (2024-2029)
7 Asia-Pacific Epigenetics Instrument by Region
7.1 Asia-Pacific Epigenetics Instrument Historic Market Size by Region
7.1.1 Asia-Pacific Epigenetics Instrument Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Epigenetics Instrument Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Epigenetics Instrument Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Epigenetics Instrument Forecasted Market Size by Region
7.2.1 Asia-Pacific Epigenetics Instrument Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Epigenetics Instrument Sales in Value by Region (2024-2029)
8 Latin America Epigenetics Instrument by Country
8.1 Latin America Epigenetics Instrument Historic Market Size by Country
8.1.1 Latin America Epigenetics Instrument Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Epigenetics Instrument Sales in Volume by Country (2018-2023)
8.1.3 Latin America Epigenetics Instrument Sales in Value by Country (2018-2023)
8.2 Latin America Epigenetics Instrument Forecasted Market Size by Country
8.2.1 Latin America Epigenetics Instrument Sales in Volume by Country (2024-2029)
8.2.2 Latin America Epigenetics Instrument Sales in Value by Country (2024-2029)
9 Middle East and Africa Epigenetics Instrument by Country
9.1 Middle East and Africa Epigenetics Instrument Historic Market Size by Country
9.1.1 Middle East and Africa Epigenetics Instrument Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Epigenetics Instrument Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Epigenetics Instrument Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Epigenetics Instrument Forecasted Market Size by Country
9.2.1 Middle East and Africa Epigenetics Instrument Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Epigenetics Instrument Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Illumina (US)
10.1.1 Illumina (US) Company Information
10.1.2 Illumina (US) Introduction and Business Overview
10.1.3 Illumina (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Illumina (US) Epigenetics Instrument Products Offered
10.1.5 Illumina (US) Recent Development
10.2 Thermo Fisher (US)
10.2.1 Thermo Fisher (US) Company Information
10.2.2 Thermo Fisher (US) Introduction and Business Overview
10.2.3 Thermo Fisher (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Thermo Fisher (US) Epigenetics Instrument Products Offered
10.2.5 Thermo Fisher (US) Recent Development
10.3 Diagenode (Belgium)
10.3.1 Diagenode (Belgium) Company Information
10.3.2 Diagenode (Belgium) Introduction and Business Overview
10.3.3 Diagenode (Belgium) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Diagenode (Belgium) Epigenetics Instrument Products Offered
10.3.5 Diagenode (Belgium) Recent Development
10.4 QIAGEN (Netherlands)
10.4.1 QIAGEN (Netherlands) Company Information
10.4.2 QIAGEN (Netherlands) Introduction and Business Overview
10.4.3 QIAGEN (Netherlands) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.4.4 QIAGEN (Netherlands) Epigenetics Instrument Products Offered
10.4.5 QIAGEN (Netherlands) Recent Development
10.5 Merck Millipore (US)
10.5.1 Merck Millipore (US) Company Information
10.5.2 Merck Millipore (US) Introduction and Business Overview
10.5.3 Merck Millipore (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merck Millipore (US) Epigenetics Instrument Products Offered
10.5.5 Merck Millipore (US) Recent Development
10.6 Abcam (UK)
10.6.1 Abcam (UK) Company Information
10.6.2 Abcam (UK) Introduction and Business Overview
10.6.3 Abcam (UK) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abcam (UK) Epigenetics Instrument Products Offered
10.6.5 Abcam (UK) Recent Development
10.7 Active Motif (US)
10.7.1 Active Motif (US) Company Information
10.7.2 Active Motif (US) Introduction and Business Overview
10.7.3 Active Motif (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Active Motif (US) Epigenetics Instrument Products Offered
10.7.5 Active Motif (US) Recent Development
10.8 New England Biolabs (US)
10.8.1 New England Biolabs (US) Company Information
10.8.2 New England Biolabs (US) Introduction and Business Overview
10.8.3 New England Biolabs (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.8.4 New England Biolabs (US) Epigenetics Instrument Products Offered
10.8.5 New England Biolabs (US) Recent Development
10.9 Agilent (US)
10.9.1 Agilent (US) Company Information
10.9.2 Agilent (US) Introduction and Business Overview
10.9.3 Agilent (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Agilent (US) Epigenetics Instrument Products Offered
10.9.5 Agilent (US) Recent Development
10.10 Zymo Research (US)
10.10.1 Zymo Research (US) Company Information
10.10.2 Zymo Research (US) Introduction and Business Overview
10.10.3 Zymo Research (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Zymo Research (US) Epigenetics Instrument Products Offered
10.10.5 Zymo Research (US) Recent Development
10.11 PerkinElmer (US)
10.11.1 PerkinElmer (US) Company Information
10.11.2 PerkinElmer (US) Introduction and Business Overview
10.11.3 PerkinElmer (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.11.4 PerkinElmer (US) Epigenetics Instrument Products Offered
10.11.5 PerkinElmer (US) Recent Development
10.12 Bio-Rad (US)
10.12.1 Bio-Rad (US) Company Information
10.12.2 Bio-Rad (US) Introduction and Business Overview
10.12.3 Bio-Rad (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bio-Rad (US) Epigenetics Instrument Products Offered
10.12.5 Bio-Rad (US) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Epigenetics Instrument Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Epigenetics Instrument Industrial Chain Analysis
11.4 Epigenetics Instrument Market Dynamics
11.4.1 Epigenetics Instrument Industry Trends
11.4.2 Epigenetics Instrument Market Drivers
11.4.3 Epigenetics Instrument Market Challenges
11.4.4 Epigenetics Instrument Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Epigenetics Instrument Distributors
12.3 Epigenetics Instrument Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
